Steve Duffy, Author at Hematology Advisor
Steve Duffy

Steve Duffy

Digital Content Editor https://www.hematologyadvisor.com
Steve Duffy is the digital content editor for MPR, part of the Medical Communications Group of Haymarket Media. He holds a BA in media and communications from Dundalk Institute of Technology (Ireland) and an MA in journalism from Griffith College, Dublin, Ireland.

All articles by Steve Duffy

FDA Approves Epoetin Alfa Biosimilar Retacrit

The approval of Retacrit was based on a review of evidence that included human pharmacokinetic/pharmacodynamic data and clinical immunogenicity data which demonstrated a high degree of similarity between Retacrit and its reference product.